FUT2

Source: Wikipedia, the free encyclopedia.

FUT2
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_001097638
NM_000511

NM_001271993
NM_018876

RefSeq (protein)

NP_000502
NP_001091107

NP_001258922
NP_061364

Location (UCSC)Chr 19: 48.7 – 48.71 MbChr 7: 45.3 – 45.32 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Galactoside 2-alpha-L-fucosyltransferase 2 is an enzyme that in humans is encoded by the FUT2 (fucosyltransferase 2) gene.[5][6]

FUT2 is a key

ABO blood group antigens,[7]
and determines "secretor status"—the presence of blood group antigens in bodily fluids such as saliva. Beyond its role in blood group antigen synthesis, FUT2 influences cell-cell interactions, modulates the composition of the gut microbiome, and impacts susceptibility to infections and autoimmune diseases, highlighting its broad significance in human health and disease.

Approximately 20% of Caucasians are

non-secretors due to the G428A (rs601338) and C571T (rs492602?) nonsense mutations in FUT2 and therefore have strong although not absolute protection from the norovirus GII.4.[citation needed
]\

Role in secretor status

The FUT2 gene determines an individual's secretor status by encoding an enzyme responsible for the expression of histo-blood group antigens in bodily secretions. Approximately 70–80% of people are

secretors, meaning they possess at least one functional FUT2 allele.[8]
Those who are homozygous for a nonfunctional allele are termed non-secretors, which has important health implications.

Clinical significance

Non-secretors display altered susceptibility to both infectious and autoimmune diseases. While they exhibit increased resistance to certain viral pathogens like norovirus,

Impact on the gut microbiome

Loss-of-function mutations in FUT2 dramatically alter the composition of the gut microbiome. Non-secretors have distinct microbial profiles compared to secretors, with studies reporting a reduction in Escherichia species and a rise in pro-inflammatory taxa.[12] Notably, non-secretors also exhibit increased levels of butyrate-producing bacteria, which are generally considered beneficial.

Consequences for microbial metabolism

Although FUT2 does not directly regulate microbial metabolism, its influence on microbial community structure can indirectly affect metabolite production. The enrichment of butyrate producers in non-secretors may represent a compensatory mechanism, but this benefit may be insufficient to counterbalance the elevated inflammatory potential of the overall microbiome. Thus, FUT2 loss-of-function variants may skew the microbiome toward a pro-inflammatory state, potentially exacerbating conditions such as inflammatory bowel disease (IBD) and masking the protective effects of beneficial metabolites like butyrate.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000176920Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000055978Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. S2CID 30777695
    .
  6. ^ "Entrez Gene: FUT2 fucosyltransferase 2 (secretor status included)".
  7. ^ "Names for H (ISBT 018) Blood Group Alleles" (PDF). www.isbtweb.org. Archived from the original (PDF) on 2019-08-28. Retrieved 2019-10-13.
  8. ^
    PMID 25744498
    .
  9. .
  10. .
  11. .
  12. .

Further reading

This page is based on the copyrighted Wikipedia article: FUT2. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy